Chi-Med Reports 2019 Interim Results and Provides Updates on Key Clinical Programs

Ads

You May Also Like

Nexttobe Extends Loan to Oasmia Pharmaceutical

Oasmia Pharmaceutical AB (NASDAQ: OASM), a developer of a new generation of drugs within ...